Legal Representation
Attorney
Jeffrey H. Greger
USPTO Deadlines
Next Deadline
1400 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-06-06)
Due Date
June 06, 2029
Grace Period Ends
December 06, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 18, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Oct 3, 2023 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Sep 6, 2023 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Sep 6, 2023 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Sep 6, 2023 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Jun 6, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 6, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| May 1, 2023 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Apr 12, 2023 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Apr 12, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Mar 21, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 21, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 21, 2023 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Mar 1, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 1, 2023 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Mar 1, 2023 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Feb 10, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 18, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 18, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 18, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Aug 17, 2022 | RFNP | P | REFUSAL PROCESSED BY IB | Loading... |
| Jul 29, 2022 | ATRV | O | ATTORNEY REVIEW COMPLETED | Loading... |
| Jul 28, 2022 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Jul 27, 2022 | LIME | X | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | Loading... |
| Jul 27, 2022 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jul 1, 2022 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jun 30, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 28, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| May 29, 2022 | LIMG | M | LIMITATION OF GOODS RECEIVED FROM IB | Loading... |
| Nov 16, 2021 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Nov 12, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Nov 11, 2021 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical and veterinary products, namely, preparations for the treatment of gut dysbiosis related diseases; chemical preparations for medical or pharmaceutical use, namely, for the treatment of gut dysbiosis related diseases; chemical preparations for pharmaceutical or medical use, namely microbiotherapy preparations for intestinal microbiome repair; bacteriological preparations for medical or veterinary use; bacterial preparations for medical or veterinary use; biological preparations for medical or veterinary use; culture media for bacteriology; chemico-pharmaceutical products, namely, for the treatment of gut dysbiosis related diseases; microbiotherapy preparations for medical use for intestinal microbiome repair
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Evaluations and assessments in the fields of science and technology provided by engineers; scientific and technical research in the field of biomarkers, nutrition, microbiotherapy, bacteriotherapy, and therapies meant to have an effect on the gut microbiota functions; research and development of new products for third parties; technical project studies, namely, engineering services in the nature of technical project planning for the manufacture, control and traceability of pharmaceutical products having an effect on gut microbiota or biomarkers aiming at characterizing the gut microbiota; chemical analysis; chemistry services, namely, laboratory research in the field of chemistry; conducting clinical trials for others; surveying engineering work; scientific laboratory services; research in biology, bacteriology, chemistry and physics; scientific research in the field of microbiotherapy
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of the letters "MA" above the letters "AT". The letters "M" and "T" are in dark blue and each letter "A" is light blue. To the right of the letters is a light blue vertical line. To the left of the lower letter "A" is a stylized light blue feather design. Above the lower letter "A" is a light blue circumflex. The color white represents background and is not claimed as a part of the mark.
Color Claim
The color(s) light blue and dark blue is/are claimed as a feature of the mark.
Classification
International Classes
005
042